Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.

Translated title of the contribution: Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
  • J.B. Tuynman
  • , C.J. Buskens
  • , K. Kemper
  • , F.J. ten Kate
  • , G.J.A. Offerhaus
  • , D.J. Richel
  • , J.J. van Lanschot

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionNeoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
Original languageUndefined/Unknown
Pages (from-to)84084-84089
Number of pages6
JournalAnnals of Surgery
Volume242
Publication statusPublished - 2005

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde (GENK)
  • Geneeskunde(GENK)
  • Algemeen onderzoek
  • Internal medicine

Cite this